MTVA
MetaVia Inc.
NASDAQ: MTVA · HEALTHCARE · BIOTECHNOLOGY
$1.41
+5.22% today
Updated 2026-10-09
Market cap
$10.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.45
Dividend yield
—
52W range
$1 – $15
Volume
0.1M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-3.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →274 stocks currently score above 75
Price targets
Analyst target
$19.33
+1270.92%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.03x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -3.49 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-3.76M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-13.97M | $-12.47M | $-27.59M | $-12.97M | $-5.32M |
| EPS | — | — | — | — | $-2.45 |
| Free cash flow | $-11.71M | $-10.85M | $-24.72M | $-15.70M | $-3.76M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
MetaVia Inc. trades at $1.41. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -3.49, it sits in the distress.
Frequently asked questions
What is MetaVia Inc.'s stock price?
MetaVia Inc. (MTVA) trades at $1.41.
Is MetaVia Inc. overvalued?
MetaVia Inc. carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of MetaVia Inc. (MTVA)?
The 12-month analyst consensus target is $19.33, about 1270.9% above the current $1.41. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
MetaVia Inc.'s Altman Z-Score is -3.49, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-195.10%
Beta0.94
50D MA$1.58
200D MA$2.50
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—